The Cut Narrative Is Dead: Three consecutive upside payroll surprises plus a stable 4.3% unemployment rate take the labor-side reason for cuts off the table. Fed funds futures now embed roughly 60% odds of at least one 25 bp hike by year-end. Until Wednesday’s CPI, every long-duration asset trades against the 2-year.
The Chip Selloff Forced a Real Rotation: AVGO’s record AI quarter met softer custom-silicon commentary, then mutated into capitulation. The rotation it triggered is real: defensives, transports, banks, insurance, utilities, and REITs swept into Early Breakout in a single session, and the entire May tech leadership board was wiped from Confirmed Outperformer.
Energy Leadership Has Inverted: Crude (USO), broad commodities (DBC), Oil Services (OIH), and Oil & Gas E&P (XOP) all now show deteriorating relative-strength trajectory despite firm spot prices. The Iran-war thematic stays alive in headlines; the rotation data says the institutional bid is fading.
The Cleanest Forward Signal Is Enterprise AI & Software, Not GPUs: Cybersecurity, Cloud Computing, AI / Big Data, and Software industry leadership all advanced this week. Memory short-put underwriting on MU ($360M anchor) and GOOGL’s $302M at-the-money short put confirm institutional capital is paying to own enterprise hyperscaler exposure lower, while paying premium to fade foundry and GPU.
OptionsPlay Trade Ideas: The Daily Brief
💰 The Income Generators (High Probability, Cash Flow)
MDT: Sell a put vertical to collect premium on a healthcare name breaking back above $80 as defensives catch the rotation bid.
🚀 The Growth Seekers (Higher Risk, Max Reward)
SPG: Long call vertical riding the early-breakout in REITs, targeting a continuation toward $230.
🛡️ The Portfolio Protectors (Hedges & Bearish Bets)
(No trades in this category today)
1. MDT ($81.98): Healthcare Rotation Reclaims the $80 Shelf
We’re betting on: A healthcare laggard turning the corner. Medtronic just posted its highest annual revenue growth in a decade (Q4 +9.9% reported, +6.6% organic), William Blair upgraded the stock to Outperform on ramping launches, and the planned diabetes spin-off frees management to concentrate firepower on faster-growing cardiac, neuro, and surgical-robotics franchises.
The Trade: Sell to Open the MDT Jul 24, 2026 81/77 Put Vertical @ $1.76 Credit.
🟢 BUY TO OPEN Jul 24, 2026 77 Put @ $1.09
🔴 SELL TO OPEN Jul 24, 2026 81 Put @ $2.85
Trade Metrics: POP: 62.89% | Collect $176 per contract vs. a Max Risk of $224 (1.27:1).
The Setup: We’re seeing rotation into healthcare and MDT just reclaimed its $80 resistance level and 50-day SMA as relative strength and trends improve. The 1M trend has flipped bullish and the stock crossed above its 50-day average at $81.07 today, with the Affera/Sphere-9 pulsed-field ablation platform and the newly FDA-cleared Hugo surgical robot driving the fundamental re-rating. Selling the 81/77 put vertical lets us collect premium while defining risk just below the $79.24 breakeven and the reclaimed support shelf. With 44 days to expiry and a 62.89% probability of profit, time decay works in our favor as long as MDT holds above $81.
Management:
Stop Loss: Buy back the spread at $3.52 (100% loss of credit received).
Take Profit: Buy back the spread at $0.88 (50% of max gain).
2. SPG ($211.89): Riding the REIT Rotation to $230
We’re betting on: The best-in-class mall REIT compounding 12 to 13% cash leasing spreads at 96% occupancy and riding the fresh institutional rotation into REITs. Q1 2026 was a blowout: Real Estate FFO of $3.17 nearly doubled the $1.51 consensus, management raised full-year FFO guidance to $13.10 to $13.25, and hiked the dividend, signaling conviction that the high-quality retail bid is durable.
The Trade: Buy to Open the SPG Jul 17, 2026 210/230 Call Vertical @ $7.00 Debit.
🟢 BUY TO OPEN Jul 17, 2026 210 Call @ $7.90
🔴 SELL TO OPEN Jul 17, 2026 230 Call @ $0.90
Trade Metrics: POP: 36.72% | Pay $700 per contract vs. a Max Reward of $1,300 (1.86:1).
The Setup: The recent breakout above $205 on strong volume triggered our early-breakout detector and puts the $230 target into play. SPG carries a 9/10 relative-strength score with both its 1M and 6M trends bullish, and price is riding cleanly above a rising 50-day average near all-time highs. This is the macro rotation in action: REITs swept into Early Breakout this week as the rate repricing pushed capital out of tech leadership and into rate-sensitive defensives. With resistance at $213 already giving way and strong support at $193, the 210/230 call vertical captures the continuation to $230 with fully defined risk.
Management:
Stop Loss: Sell the spread at $3.50 (50% loss of premium).
Take Profit: Sell the spread at $12.25 (75% gain on premium).
Share this on